1.
Liu Z, Doan QV, Blumenthal P, Dubois RW. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. <em>Value Health</em>. 2007;10(3):183-194. doi: 10.1111/j.1524-4733. 2007.00168.x
2.
Toz E, Sanci M, Ozcan A, Beyan E, Inan AH. Comparison of classic terminology with the FIGO PALM-COEIN system for classification of the underlying causes of abnormal uterine bleeding. <em>Int J Gynaecol Obstet.</em> 2016;133(3):325-328. doi: 10.1016/j.ijgo.2015.09.033
3.
Wouk N, Helton M. Abnormal uterine bleeding in premenopausal women. <em>Am Fam Physician</em>. 2019;99(7):435-443.
4.
Munro MG, Critchley HO, Fraser IS. The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them? <em>Am J Obstet Gynecol.</em> 2012;207(4):259-265. doi: 10.1016/j.ajog.2012.01.046
5.
Fraser IS, Critchley HO, Broder M, Munro MG. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. <em>Semin Reprod Med</em>. 2011;29(5):383-390. doi: 10.1055/s-0031-1287662
6.
Woolcock JG, Critchley HO, Munro MG, Broder MS, Fraser IS. Review of the confusion in current and historical terminology and definitions for disturbances of menstrual bleeding. <em>Fertil Steril.</em> 2008;90(6):2269-2280. doi: 10.1016/j.fertnstert.2007.10.060
7.
Fraser IS, Critchley HO, Munro MG, Broder M, Writing Group for this Menstrual Agreement Process. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. <em>Fertil Steril</em>. 2007;87(3):466-476. doi: 10.1016/j.fertnstert.2007.01.023
8.
Fraser IS, Critchley HO, Munro MG, Broder M. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding? <em>Hum Reprod.</em> 2007;22(3):635-643. doi: 10.1093/humrep/del478
9.
Munro MG, Critchley HO, Broder MS, Fraser IS, FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. <em>Int J Gynaecol Obstet.</em> 2011;113(1):3-13. doi: 10.1016/j.ijgo.2010.11.011
10.
Munro MG, Critchley HOD, Fraser IS, FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. <em>Int J Gynaecol Obstet.</em> 2018;143(3):393-408. doi: 10.1002/ijgo.12666
11.
Munro MG, Critchley HOD, Fraser IS, FIGO Menstrual Disorders Committee. Corrigendum to “The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions” [Int J Gynecol Obstet 143(2018) 393-408.]. <em>Int J Gynaecol Obstet.</em> 2019;144(2):237. doi: 10.1002/ijgo.12709
12.
Merrill RM. Hysterectomy surveillance in the United States, 1997 through 2005. <em>Med Sci Monit</em>. 2008;14(1):CR24-CR31
13.
<div>
13. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol.</div>
<div>
2003;188(1):100-107. doi: 10.1067/mob.2003.99</div>
14.
<div>
Serden SP, Brooks PG. Treatment of abnormal uterine bleeding with the gynecologic resectoscope. J Reprod Med. 1991;36(10):697-699.</div>
15.
<div>
Stewart EA, Nicholson WK, Bradley L, Borah BJ. The burdenof uterine fibroids for African-American women: results of anational survey. J Womens Health (Larchmt). 2013;22(10):807-816. doi: 10.1089/jwh.2013.4334</div>
16.
<div>
Ferraz Z, Nogueira-Martins N, Nogueira-Martins F.Adenomyosis: back to the future? Facts Views Vis Obgyn.2017;9(1):15-20.</div>
17.
<div>
Studzinski Z, Filipczak A, Branicka D. The analysis of thecoexistence of endometrial carcinoma and uterine myoma.Ginekol Pol. 2000;71(3):123-129.</div>
18.
<div>
Kinay T, Ozturk Basarir Z, Firtina Tuncer S, Akpinar F,Kayikcioglu F, Koc S. Prevalence of endometrial polyps coexistingwith uterine fibroids and associated factors. Turk J Obstet Gynecol.2016;13(1):31-36. doi: 10.4274/tjod.36043</div>
19.
<div>
Salim S, Won H, Nesbitt-Hawes E, Campbell N, Abbott J.Diagnosis and management of endometrial polyps: a criticalreview of the literature. J Minim Invasive Gynecol. 2011;18(5):569-581. doi: 10.1016/j.jmig.2011.05.018</div>
20.
<div>
Taran FA, Stewart EA, Brucker S. Adenomyosis: epidemiology,risk factors, clinical phenotype and surgical and interventionalalternatives to hysterectomy. Geburtshilfe Frauenheilkd.2013;73(9):924-931. doi: 10.1055/s-0033-1350840</div>
21.
<div>
Wynants L, Verbakel JYJ, Valentin L, et al. The risk of endometrialmalignancy and other endometrial pathology in womenwith abnormal uterine bleeding: an ultrasound-based modeldevelopment study by the IETA Group. Gynecol Obstet Invest.2022;87(1):54-61. doi: 10.1159/000522524</div>
22.
<div>
Vijayaraghavan A Sr, Jadhav C, Pradeep B, Bindu H, KumaranS. A Histopathological study of endometrial biopsy samples inabnormal uterine bleeding. Cureus. 2022;14(11):e31264. doi:10.7759/cureus.31264</div>
</ol>
<p>
